Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei

Cefiderocol for extensively-drug resistant gram-negative bacterial infections: real-world experience from a case-series and review of the literature

(2020) Sandra Zingg et al.   Open Forum Infectious Diseases

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report

(2019) Enrico Maria Trecarichi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Co-Infections of Two Strains of NDM-1 and OXA-232 Co-producing Klebsiella pneumoniae in a Kidney Transplant Patient

(2019) Deisy A. Contreras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin

(2019) Takayuki Katsube et al.   CLINICAL INFECTIOUS DISEASES

Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens

(2019) Robert A Bonomo   CLINICAL INFECTIOUS DISEASES

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study

(2019) Matteo Bassetti et al.   Infection and Drug Resistance

Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas aeruginosa and ESBL-producing Klebsiella pneumoniae in a Pediatric Patient

(2019) Zain I. Alamarat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects

(2018) Yutaka Saisho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa

(2018) Jonathan D Edgeworth et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function

(2016) Takayuki Katsube et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections

(2008) George G Zhanel et al.   Expert Review of Anti-Infective Therapy